WEIGHT-loss jabs are taking the world by storm, with a staggering half a million of us now using them. The injections have ...

Drugs like Ozempic, Mounjaro and Saxenda have swept the globe since emerging on the market late last decade, and an estimated 20,000 Australians currently use the drugs for weight loss.

Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...

While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.

The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

The General Pharmaceutical Council (GPhC) have published the new guidance for prescribing weight loss injections such as ...

Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with onli ...

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

Novo Nordisk - which manufactures Wegovy, Ozempic and Saxenda - misreported, under-reported or did not disclose funding it ...